These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38450511)
61. Regulation of triglyceride metabolism by Angiopoietin-like proteins. Mattijssen F; Kersten S Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269 [TBL] [Abstract][Full Text] [Related]
62. ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesterolaemia: a shot in the arm for evinacumab. Watts GF; Tamehri Zadeh SS; Chan DC Eur Heart J; 2024 Jul; 45(27):2435-2438. PubMed ID: 38856677 [No Abstract] [Full Text] [Related]
63. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. Ando Y; Shimizugawa T; Takeshita S; Ono M; Shimamura M; Koishi R; Furukawa H J Lipid Res; 2003 Jun; 44(6):1216-23. PubMed ID: 12671033 [TBL] [Abstract][Full Text] [Related]
65. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. Conklin D; Gilbertson D; Taft DW; Maurer MF; Whitmore TE; Smith DL; Walker KM; Chen LH; Wattler S; Nehls M; Lewis KB Genomics; 1999 Dec; 62(3):477-82. PubMed ID: 10644446 [TBL] [Abstract][Full Text] [Related]
66. Imaging the ANGPTL3/8-mediated regulation of lipoprotein lipase in the heart. Yang Y; Jung H; Konrad RJ; Fong LG; Young SG J Lipid Res; 2023 Dec; 64(12):100467. PubMed ID: 37898405 [No Abstract] [Full Text] [Related]
67. Furin is the primary in vivo convertase of angiopoietin-like 3 and endothelial lipase in hepatocytes. Essalmani R; Susan-Resiga D; Chamberland A; Asselin MC; Canuel M; Constam D; Creemers JW; Day R; Gauthier D; Prat A; Seidah NG J Biol Chem; 2013 Sep; 288(37):26410-8. PubMed ID: 23918928 [TBL] [Abstract][Full Text] [Related]
68. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia. Ruscica M; Zimetti F; Adorni MP; Sirtori CR; Lupo MG; Ferri N Pharmacol Res; 2020 Mar; 153():104653. PubMed ID: 31931117 [TBL] [Abstract][Full Text] [Related]
69. The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. Shan L; Yu XC; Liu Z; Hu Y; Sturgis LT; Miranda ML; Liu Q J Biol Chem; 2009 Jan; 284(3):1419-24. PubMed ID: 19028676 [TBL] [Abstract][Full Text] [Related]
70. Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche. Zheng J; Huynh H; Umikawa M; Silvany R; Zhang CC Blood; 2011 Jan; 117(2):470-9. PubMed ID: 20959605 [TBL] [Abstract][Full Text] [Related]
71. Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4. Bini S; D'Erasmo L; Astiarraga B; Minicocci I; Palumbo M; Pecce V; Polito L; Di Costanzo A; Haeusler RA; Arca M; Ferrannini E; Camastra S Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2647-2654. PubMed ID: 36163215 [TBL] [Abstract][Full Text] [Related]
72. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity. Chen YQ; Yang Y; Zhen EY; Beyer TP; Li H; Wen Y; Ehsani M; Jackson N; Xie K; Jung H; Scheithauer JL; Kumari A; Birrane G; Russell AM; Balasubramaniam D; Liao Z; Siegel RW; Qian Y; Ploug M; Young SG; Konrad RJ Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2322332121. PubMed ID: 38625948 [TBL] [Abstract][Full Text] [Related]
73. Regulation of lipoprotein metabolism by ANGPTL3, ANGPTL4, and ANGPTL8. Sylvers-Davie KL; Davies BSJ Am J Physiol Endocrinol Metab; 2021 Oct; 321(4):E493-E508. PubMed ID: 34338039 [TBL] [Abstract][Full Text] [Related]
74. New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases. Su X; Peng DQ Lipids Health Dis; 2018 Jan; 17(1):12. PubMed ID: 29334984 [TBL] [Abstract][Full Text] [Related]
75. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism. Wen Y; Chen YQ; Konrad RJ Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908 [TBL] [Abstract][Full Text] [Related]
76. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif. Balasubramaniam D; Schroeder O; Russell AM; Fitchett JR; Austin AK; Beyer TP; Chen YQ; Day JW; Ehsani M; Heng AR; Zhen EY; Davies J; Glaesner W; Jones BE; Siegel RW; Qian YW; Konrad RJ J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397 [TBL] [Abstract][Full Text] [Related]